With the recent convocation of the 119th Congress, a change in administration, and resignation of USPTO Director Vidal, pharmaceutical patent ...

ENCINITAS, CA - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a small-cap biotech firm with a market capitalization of $10.47 million and strong financial health according to InvestingPro analysis, has ...

Silo currently has patents issued and numerous expanded patent applications pending for SPC-15, a technology that was ...

Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...

Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for ...

Adial Pharmaceuticals, Inc. has announced the issuance of a new patent that enhances their methods for identifying and treating patients with genetic markers associated with substance use ...

Adial secured a new U.S. patent expanding methods for identifying genetic markers linked to substance use disorders and AD04 treatment. The company completed a pharmacokinetics study confirming ...

Adial Pharmaceuticals (ADIL) announced patent number 12,221,654 was issued on February 11, 2025, by the United States Patent and Trademark ...

The success of Epidiolex prompted several companies to attempt to create generic versions. Jazz Pharmaceuticals plc (NASDAQ: ...

ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that the United States Patent and Trademark Office (USPTO ...